Aspen is now a significant global pharma company, supplying branded and generic pharmaceuticals in more than 150 countries across the world. It was founded by Stephen Saad less than 15 years ago. It has a Market Cap of R125.9 billion, a PE of 32.9 and a dividend yield of 0.5%. David Lerche from Avior Research. Host Bronwyn Nielsen and resident expert Paul Theron from Vestact decide whether Aspen is hot or not.



Source: CNBC Africa